Microneedling Plus the Universal Peel For Acne Scarring
Launched by ENGLEWOOD HOSPITAL AND MEDICAL CENTER · Jun 23, 2014
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject \> 18 and \< 60 years of age.
- • Subject has skin type III, IV, V, or VI as defined by the Fitzpatrick Classification Scale.
- • Subject has acne scarring as defined by the Goodman and Baron Grading System.
- Exclusion Criteria:
- • Subject currently has moderate to severe acne on the face.
- • Subject has an active infection.
- • Subject is pregnant or lactating.
- • Subject has a history of a bleeding disorder.
- • Subject is taking an anti-coagulant.
- • Subject has a history of keloidal tendency.
- • Subject has received ablative or non-ablative laser treatments in the previous 6 months.
- • Subject has taken Accutane within the previous 3 months.
Trial Officials
Naana Boakye, MD
Principal Investigator
Englewood Hospital and Medical Center
About Englewood Hospital And Medical Center
Englewood Hospital and Medical Center is a leading healthcare institution dedicated to providing high-quality patient care and advancing medical research. Located in Englewood, New Jersey, the hospital is committed to innovative clinical practices and the development of new treatments through rigorous clinical trials. With a diverse team of experienced healthcare professionals and researchers, Englewood Hospital fosters a collaborative environment that prioritizes patient safety and ethical standards in research. The institution’s robust clinical trial program aims to explore novel therapies and improve health outcomes, contributing to the advancement of medical knowledge and the well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Englewood Cliffs, New Jersey, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials